Sir,
The last 100 years have seen a revolution in the understanding of adrenal disease and its surgical treatment. The isolation of its hormones, the detailed study of the adrenal medulla and the cortex together with the enormous expansion of surgical methods served as catalysts to this revolution. The Greek word for adrenal (epinephridio, from the Greek epi, upon, and nephros, kidney) dates back to the age of Homer who mentions the adrenal glands. In his Iliad (21, 204) , when describing Achilles' killing of an adversary, Homer writes: "About him, indeed, the eels and fishes were busied, eating and nibbling the fat around his kidneys". 1 Although Homer seems to be aware of the tissue upon the kidneys, translated by Buckley as fat, 1 and because of his extensive anatomical knowledge, he appears here to be referring to the left flank in general. In the Bible, Leviticus (3:4) contains a similar description of the adrenals, which again were understood to be integral parts of the kidneys: "the kidneys and the fat that is on them at the loins". 2 Galen was the first to provide a detailed description of the adrenal veins, defining the adrenal glands as "bodies around the kidneys": "For when the 3, 4 Bartolomeo Eustachio (or Bartholomeus Eustachius), a famous Italian anatomist who flourished in 16th century Rome, was the first to recognize the adrenal gland as a distinct anatomical entity. His treatise titled "Opuscula Anatomica" and published in Venice in 1564 contains the first description of the adrenal glands, which he labeled "glandulae quae renibus incumbent" (glands lying on the kidney). 5 Eustachius' original description of the adrenals provided a new field for argument with his contemporaries over the ensuing years. Arcangelo Piccolomini (1562-1605) in his treatise 8 vented bitter criticism of Eustachius' findings, reporting that the adrenal glands do not deserve special attention, as they represent rare renal excrescences, caused in a way similar to that causing supernumerary digits: 6, 7 The fact that the glands were rarely identified was underlined by André Du Laurens, physician to Henry IV of France, who in 1640 wrote: "Eustachius claims to find a gland above the kidneys. Sometimes we saw that too; often, however, we stated that there was no such gland". 6 In 1627, Casserius, a prominent anatomist of Padua, validated Eustachius' discovery and provided illustrations of the adrenal glands, which he termed corpuscula reni incumbentia sive renes succenturiati (renal corpuscles lying on or above the kidney).
9 Casserius' depiction ( Figure 2 ) was the first to appear, as Eustachius' plates were not published until two centuries after being engraved. His work, however, did not receive the attention it deserved. Marcus Aurelius Severinus (1580-1658) is thought to have been the first to mention a relation between the left adrenal gland and epididymis through an excretory duct. This discovery, suggestive of an "adrenogonadal relationship", was largely overlooked and attributed to Antonio Maria Valsalva (1666-1723) in 1719. 6 The name, suprarenal gland was introduced by Riolan the Younger in 1655 6 and the "modern" terms medulla and cortex were introduced in 1836 by Nagel. 10 By the early 18 th century, medicine had over 20 theories seeking to explain the function and physiology of the adrenal glands, whose presence was by this time well-established. A comprehensive overview of all these theories is beyond the scope of this study. Casper Bartholin, who considered the adrenals to be hollow organs filled with black bile, called them capsulae atrabiliarae, while an important milestone was reached in 1656 by Thomas Wharton. Wharton was the first to associate the adrenal glands with the nervous system, suggesting a possible role for them in transferring substances from the nerves to the circulation. 6 His idea was affirmed 200 years later when Kölliker provided the first accurate description of the microscopic anatomy of the adrenal gland in 1852. 11 In 1716, the Academy of Sciences of Bordeaux held a competition offering a prize for an answer to the question "What is the function of the suprarenal glands?" The then 29-year-old French philosopher Montesquieu was asked to judge the competition. However, finding no contestant convincing enough to be awarded the prize, 12 he expressed the hope that the problem would someday be solved. 13 In 1805, Cuvier established that the adrenals were solid structures 6 16 Osler, however, kept up his research and in the same year published his experience with 6 addisonian patients, including one who greatly benefited from the use of the extract. 17 In 1897, John Jacob Abel became to first to isolate an endocrine secretion as a chemically-pure substance, i.e. epinephrine. Some years later Jokichi Takamine and Thomas Bell Aldrich Takamine were the first to independently isolate epinehrine in a crystalline form. 6 The first description of a successful adrenalectomy was reported in 1890 by Thornton, who one year earlier employed a T-shaped incision to remove a 20-pound adrenal tumor with the left kidney from a 36-year-old woman. The tumor was most probably a malignant adrenocortical carcinoma and the patient died 2 years later from recurrence. 18 In 1932, Lennox Broster described a unilateral, transpleural, transdiaphragmatic adrenalectomy through a long posterior, intercostal approach for adrenogenital syndrome associated with cortical hyperplasia. 19 In the same year, Cushing was the first to recognize the role of the adrenal cortex in pituitary baseophilism, describing an endocrine syndrome causing hypercortisolism through excessive secretion by the cortex. 20 The disease, now referred to as Cushing syndrome, was termed "suprarenal cortical syndrome", a term also sometimes used to describe adrenal virilism. 21 By this time, the search for potent cortical extracts had reached its peak. The research was primarily led by Edward Calvin Kendall at the Mayo Clinic and Reichstein in Zürich. Their intensive efforts resulted in the isolation of cortisone and its essential components in the late 1930s. 22 In 1934, Walters et al at the Mayo Clinic were the first to report ten cases of subtotal adrenalectomy for patients with "suprarenal cortical syndrome", with a mortality rate of 30% despite using Kendall's potent cortical extracts. 23 In 1936, Hugh Young of Johns Hopkins reported a posterior approach with the removal of the 12th rib for simultaneous exposure of both adrenals in Cushing patients. 24 In 1949, James Priestley at the Mayo Clinic reported his experience in 29 adrenalectomized patients with Cushing syndrome. In the first 20 cases, a preand postoperative replacement therapy with aqueous adrenal cortical extract was employed. The last nine cases were treated with cortisone in place of aqueous adrenal cortical extract. No deaths were observed in the cortisone group, in comparison with the 30% mortality rate in the aqueous cortical extract group. 25 These results, supported by larger subsequent studies, established the use of the replacement therapy. In 1886, Felix Fränkel described an 18-year-old woman who died from progressive circulatory failure 9 days after hospital admission with paroxysmal hypertensive crises. 26 The autopsy revealed bilateral adrenal tumors, which apparently were pheochromocytomas. 27 Since no signs of Addison's disease, the only known clinical entity of adrenal pathology at the time, were observed, Fränkel attributed the death to severe nephritis, considering the adrenal tumors as latent. Similar adrenal tumors were identified in subsequent years and were termed "paragangliomas", coined by Alezais and Peyron in 1908. 28 It was not until 1912 that the term pheochromocytoma was used by Ludwig Pick to refer to tumors in the adrenals and at extra-adrenal sites. 29 The first comprehensive tumor description together with association with symptoms and signs was published 10 years later by Labbé et al. 30 In 2007, Neumann et al reviewed Fränkel's publication, addressing the hypothesis that the patient had an inherited disorder. The presence of germ-line RET mutations in four living descendants established the clinical and molecular diagnosis of MEN-2 in Fränkel's original description. 31 The first surgically treated patient with a pheochromocytoma in 1923 died in shock, the event being regarded as "disproportionate to the severity of the operation". 27 The first known successful surgical removal of a pheochromocytoma was performed on 25 February 1926 by César Roux (1857 Roux ( -1934 in Lausanne, Switzerland. The patient was a woman suffering from paroxysmal hypertensive crises who had noticed an orange-sized lump under her right costal margin, with an X-ray pattern resembling a liver tumor. The patient underwent surgical exploration and a tumor attached to the right adrenal was found and removed. The postoperative period was uneventful with no recurrence or complications during a follow-up period of 18 months. 27 The second successful removal of a pheochromocytoma was independently carried out by Charles Mayo 7 months later in Minnesota, USA. Using a flank incision, 32 Mayo removed a lemonsized tumor, apparently separate from the adrenal of a patient with paroxysmal hypertension. 27 The tumor, with the appearance of a typical pheochromocytoma, was given several names, such as "retroperitoneal malignant blastoma" and "encapsulated fibrous cellular retroperitoneal malignant neoplasm". The patient was disease-free during the follow-up period and died after 18 years from coronary thrombosis. 27 The following year, 1927, Mayo had his work published, 33 one year earlier than Roux, whose case was included in the thesis of Roland von der Mühll, a pathologist working in Lausanne, published in 1928. 34 Thus, Mayo was primarily credited with the first successful pheochromocytoma removal and Roux is best known for the Roux-en-Y anastomosis, popularized in 1893. 35 By 1940, about 20 operations for pheochromocytomas had been reported, a number that rose to 151, with a 26% mortality rate, by 1951. 27 The evolution of laparoscopic adrenalectomy serves as the first-line of therapy for the management of most functional and non-functional adrenal tumors. 36 Gagner et al were the first to report three cases of laparoscopic adrenalectomy in the lateral decubitus position in two patients with Cushing syndrome and a 60-year-old man with pheochromocytoma in 1992. 37 This technique gained widespread acceptance, being considered the most popular technique for the past decade. 38 In the same year, Higashihara et al published in Japanese a case of laparoscopic adrenalectomy for primary aldosteronism utilizing a subcutaneous steel traction method to reduce CO2 insufflation pressure. 39 The following year, the authors summed up their experience with this method reporting three patients with primary aldosteronism who underwent successful laparoscopic adrenalectomy. 40 Gagner recognizes two presentations of their findings at the American Association of Endocrine Surgery 41 and the American Surgical Association 42 as landmarks "that gave a stamp of approval for this technique", stating that "the work of a pioneer is not only to describe the technique but also to convince the world surgical community that these changes are significant". 38 In the latter of the two works, the authors reported 97 laparoscopic adrenalectomies with no mortality, no recurrence of hormonal excess and a conversion rate of 3%, suggesting that the open procedure should be reserved for cases of invasive adrenal carcinoma and malignant pheochromocytoma. 42 Mercan et al should be credited for introducing the endoscopic retroperitoneal approach in clinical practice, recording successful resection in eight patients with benign adrenal lesions in 1995. 43 Both these innovative surgical techniques simplified the procedure, resulting in less postoperative morbidity and a shorter recovery period, this becoming the new gold standard in adrenal surgery.
